Biotechnology products
| Title | Link |
|---|---|
| Biotechnology, Ethics and Government: Report to the Interdepartmental Working Group on Ethics - Winter 1998 - (125 pages) | http://strategis.ic.gc.ca/pics/bh/bioteche.pdf |
| Anna E. Morrison - The U.S. PTO's New Utility Guidelines: Will They Be Enough to Secure Gene Patent Rights? - 1 J. MARSHALL REV. INTELL. PROP. L. 142 - 2001 - (22 pages) | http://www.jmls.edu/ripl/vol1/issue1/morrison.pdf |
| Lawrence M. Sung - Part II: Judicial Issues Stranger In A Strange Land: Biotechnology and the Federal Circuit - 168 Re-Engineering Patent Law Vol. 2:167- (32 pages) | http://law.wustl.edu/Journal/2/p167sung.pdf |
| Sherry M. Knowles - Written Description and Enablement Requirements for Pharmaceutical, Chemical and Biotechnology Inventions - (36 pages) | http://www.kslaw.com/library/pdf/pharmaknowles.pdf |
| Matthew D. Kellam - Making Sense out of Antisense: The Enablement Requirement in Biotechnology After Enzo Biochem v. Calgene - 222 INDIANA LAW JOURNAL [Vol. 76:221 - (22 pages) | http://www.law.indiana.edu/ilj/v76/no1/kellam.pdf |
| Under-valuing Australia’s genetic materials by accepting broad claims in patenting genetic materials under the Patents Act 1990 (Cth) - (75 pages) | http://www.ipcr.gov.au/ipcr/SUBMIS/docs/03lawson.pdf |
| Leu Investment Research - Sector Report: Pharmaceuticals Europe – Hopes Focus on Biotechnology - December 2001 - (57 pages) | http://www.leu.ch/pdf/pharma_en.pdf |
| Elli Malki - Intellectual property and the valuation of biotechnology companies: GEN-dex versus Dow Jones - (11 pages) | http://econwpa.wustl.edu:8089/eps/fin/papers/9709/9709002.pdf |
| Andreas Pyka and Paolo Saviotti - Innovation Networks in the Biotechnology-Based Sectors - July 2001 - (35 pages) | http://www.wiwi.uni-augsburg.de/vwl/institut/paper/205.pdf |
| James G. Silva - Copyright Protection Of Biotechnology Works: Into The Dustbin Of History? - 2000 B.C. Intell. Prop. & Tech. F. 012801 - January 28, 2000 | http://infoeagle.bc.edu/bc_org/avp/law/st_org/iptf/articles/content/2000012801.html |
| Arthur Andersen - Pharmaceutical, Biomedical, and Health Services Research - Biotechnology Industries Status and Outlook - (37 pages) | http://www.andersen.com/resource2.nsf/vAttachLU/HI_BiotechIndustry/$File/HI_BiotechIndustry.PDF |
| Sean Nicholson Patricia M. Danzon Jeffrey McCullough - Biotech-Pharmaceutical Alliances as a Signal of Asset and Firm Quality - January 2002 - (46 pages) | http://hc.wharton.upenn.edu/danzon/PDF%20Files/biodeals.pdf |
| Testimony of the Biotechnology Industry Organization on Competition and Intellectual Property Law and Policy in the Knowledge e-based economy before the FTC and the DOJ on February 26, 2002 - (35 pages) | http://www.bio.org/ip/pdf/ftc022002.pdf |
| Legal protection of biotechnical inventions: Frequently Asked questions on scope and objectives of the EU Directive (98/44) | http://europa.eu.int/comm/internal_market/en/indprop/invent/2k-39.htm |
| Note for Guidance on Specifications: test procedures and acceptance criteria for biotechnological/biological products - (17 pages) | http://www.emea.eu.int/pdfs/human/ich/036596en.pdf |
| Susan Allender-Hagedorn and Charles Hagedorn - An Agricultural and Environmental Biotechnology Annoted Dictionary | http://filebox.vt.edu/cals/cses/chagedor/glossary.html |
| FDA - 2002 Workshop on Pharmacogenetics / Pharmacogenomics in Drug Development and Regulatory Decision-Making - May 16-17th, 2002 - (65 pages) | http://www.fda.gov/cder/calendar/meeting/phrma52002/workbook.pdf |
| Institute of Medicine - Stem Cells and the Future of Regenerative Medicine (September 11, 2001) - 71 pages | http://books.nap.edu/html/stem_cells/report.pdf |
| Loi fédérale relative à la recherche sur les embryons surnuméraires et sur les cellules souches embryonnaires (Loi relative à la recherche sur les embryons, LRE) Rapport explicatif sur le projet de loi - Mai 2002 - (86 pages) | http://www.bag.admin.ch/embryonen/bundesgesetz/f/erl_efg.pdf |
| Draft - Loi fédérale Projet relative à la recherche sur les embryons surnuméraires et sur les cellules souches embryonnaires | http://www.bag.admin.ch/embryonen/bundesgesetz/f/entw_efg.pdf |
| Boston University Journal of Science & Technology Law Symposium - Probing the Human Genome: Who Owns Genetic Information? - 4 B.U. J. SCI. & TECH. L. 2 - February 1997 - (43 pages) | http://www.bu.edu/law/scitech/volume4/4jstl02.pdf |
| OTA - Biotechnology in a Global Economy - OTA-BA-494 - October 1991 | http://www.wws.princeton.edu/cgi-bin/byteserv.prl/~ota/disk1/1991/9110/9110.PDF |
| Stem Cell Research: A Target Article Collection - (28 pages) | http://muse.jhu.edu/demo/ajb/2.1green.pdf |
| GeneBio - home page - "providing quality databases, software tools and services to the Life Science industry particularly in the field of proteomics" | http://www.genebio.com |
| GeneProt - home page - "goal is to become the leader in the discovery, identification and characterization of proteins and their functions for major disabling or life threatening diseases" | http://www.geneprot.com |
| BioIsrael - home page -"the hubsite of Israel`s life sciences community and the leading source of news about Israeli biotechnology and medical device companies" | http://www.bioisrael.com |
| Ashish Arora, Alfonso Gambardella,Fabio Pammolli, Massimo Riccaboni, The Nature and the Extent of the Market for Technology in Biopharmaceuticals, EPRIS, - December 2000 - (42 pages) | http://www.unisi.it/epris/abstract/biotec.doc |
| Ordonnance du 26 juin 1996 sur les essais cliniques de produits immunologiques; RS: 818.124. | http://www.admin.ch/ch/f/rs/8/818.124.1.fr.pdf |
| Q6B Guideline on Biotechnological Substances (Step 5) | http://www.ifpma.org/pdfifpma/Q6bstep4.pdf |
| Swiss Federal Office for Public Health, Annual Report 2000 on biologic products | http://www.bag.admin.ch/heilmitt/biologik/jahrb00 |
| Biotechnology Information Switzerland, Information on biotechnology with a focus on Switzerland | http://www.bioweb.ch/en/ |
| Actelion - home page - Swiss biotechnology company | http://www.actelion.com/ |
| Swiss Center for Technology Assessment - Anne Eckhard - Somatic gene therapy: Striking to the roots of disease | http://www.ta-swiss.ch/www-support/reportlists/reports_temp/ta_32a_99_kurz_e.pdf |
| J. Howard Beales III, Modification and Consumer Information: Modern Biotechnology and the Regulation of Information, 55 Food and Drug Law Journal 105-118 (2000) - (14 pages) | http://www.fdli.org/pubs/Journal%20Online/55_1/art6.pdf |
| Biotechnology Industry Organization - home page | http://www.bio.org/ |
| BIO - Genomics - PRIMER: GENOME AND GENETIC RESEARCH, PATENT PROTECTION AND 21 st CENTURY MEDICINE - July 2001 | http://www.bio.org/genomics/primer.html |
| BIO - Statement on patent-term amendments to protect diligent patent applicants and 18-month publication of patent applications before the Courts and Intellectual Property Subcommittee | http://www.bio.org/laws/tstm2261.html |
| BIO - Guide on biotechnology - (120 pages) | http://www.bio.org/aboutbio/guide2001/letter.pdf |
| The European Group on Ethics in Science and new Technologies - - Adoption of an Opinion on Ethical Aspects of Stem Cell Research and Use- January 2001 - (230 pages) | http://www.europa.eu.int/comm/european_group_ethics/docs/dp15.pdf |
| European Commission Directorate - General XII Science, Research and Development- Biotechnology R&D in Europe - 1996 - (37 pages) | http://europa.eu.int/comm/research/biotech/national.pdf |
| European Commission, Directorate - General XII Science, Research Development - Coordination of Structural Biology in Europe, National EC and Industry Joint Efforts - (156 pages) | http://europa.eu.int/comm/research/biotech/structur.pdf |
| COMMUNICATION
FROM THE COMMISSION TOWARDS A STRATEGIC VISION OF LIFE SCIENCES AND
BIOTECHNOLOGY: CONSULTATION DOCUMENT - Brussels, September 4, 2001 - (32 pages) |
http://europa.eu.int/comm/biotechnology/pdf/doc_en.pdf |
| Council of Europe - Recommendation 934 (1982) on genetic engineering | http://stars.coe.fr/ta/ta82/erec934.htm |
| Council of Europe - Recommendation 1046 (1986) on the use of human embryos and foetuses for diagnostic, therapeutic, scientific, industrial and commercial purposes | http://stars.coe.fr/ta/ta86/erec1046.htm |
| Council of Europe - RECOMMENDATION 1100 (1989)1 on the use of human embryos and foetuses in scientific research | http://stars.coe.fr/ta/ta89/erec1100.htm |
| Council of Europe - Recommendation 1240 (1994) on the protection and patentability of material of human origin | http://stars.coe.fr/ta/ta94/erec1240.htm |
| Council of Europe - Recommendation 1425 (1999) on Biotechnology and intellectual property | http://stars.coe.fr/ta/ta99/erec1425.htm |
| Council of Europe - Recommendation 1512 (2001) on the Protection of the human genome by the Council of Europe | http://stars.coe.fr/ta/TA01/EREC1512.htm |
| Council of Europe - Additional Protocol to the Oviedo Convention on the Prohibition of Cloning Human Beings and Explanatory report to the Protocol | http://www.legal.coe.int/bioethics/gb/pdf/proto.pdf |
| IBC, International Bioethics Committee - Working Group on genetic data - Draft Report on Collection, Treatment, Storage and Use of Genetic Data - September 3, 2001 | http://www.unesco.org/ibc/en/reports/DraftRep_UseOf_GenData_E.pdf |
| International Bioethics Committee (IBC)- The Use of Embryonic Stem Cells In Therapeutic Research - April 6, 2001 - (24 pages) | http://www.unesco.org/ibc/en/reports/embryonic_ibc_report.pdf |
| Le Conseil fédéral veut réglementer la recherche sur les cellules souches embryonnaires dans une loi fédérale spécifique - Press release - November 21, 2001 | http://www.bag.admin.ch/dienste/medien/2001/f/01112137.htm |
| FDA - Bovine Spongiform Encephalopathy (BSE) | http://www.fda.gov/cber/bse/bse.htm |
| FDA - CBER Guidances / Guidelines / Points to Consider | http://www.fda.gov/cber/guidelines.htm |
| Bioweb - home page - | http://www.bioweb.ch/en/ |
| BICS - home page - Biotechnology Information and Communication Switzerland of the Priority Programme Biotechnology of the Swiss National Science Foundation | http://bics.ch/en/index.php3 |
| Technology Review - Biotech - home page - "An MIT enterprise" | http://www.technologyreview.com/biotech.asp |
| Arti K. Rai & Rebecca S. Eisenberg - The Public and the Private in Biopharmaceutical Research - (20 pages) | http://www.law.duke.edu/pd/papers/raieisen.pdf |
| Pontifical Academy for life - Declaration on the production and the scientific and therapeutic use of human embryonic stem cells | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_20000824_cellule-staminali_en.html |
| Pontifical Academy for life - Reflections on Cloning | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_30091997_clon_en.html |
| Pontifical Academy for life - identity and Statute of Human Embryos | http://www.vatican.va/roman_curia/pontifical_academies/acdlife/documents/rc_pa_acdlife_doc_06041998_embrione_en.html |
| Stefano Breschi, Francesco Lissoni and Luigi Orsenigo, Success and failure in the development of biotechnology clusters: the case of Lombardy | http://nt-notes.liuc.it/ricerca/IstitutoEconomia.nsf/c6d95ba0f57aa4cac12567b0005a08ba/a13ef9d5ce2843aec1256a14006878de/$FILE/Stuttbook.PDF |
| S. Casper and H. Kettler, National Institutional Frameworks and the Hybridization of Entrepreneurial Business Models: The German and UK Biotechnology Sectors | http://www.unisi.it/epris/abstract/Casper_Kettler.doc |
| GAO - Human Fetal Tissue: Acquisition for Federally Funded Biomedical Research, October 2000, | http://www.gao.gov/archive/2000/d010065r.pdf |
| A European Parliament vote against a ban on human cloning has cleared the way for EU investment in stem cell research over the next five years. | http://europa.eu.int/comm/research/headlines.html#01 |
| Executive Committee Meeting in Sorrento 2000 - Summary Report - Patentability Requirements and Scope of Protection of Expressed Sequence Tags (ESTs), Single Nucleotide Polymorphisms (SNPs) and Entire Genomes | http://www.aippi.org/reports/q150/sr-q150-e.htm |
| OECD - The Economic Aspects of Biotechnologies related to Human Health Part I - 1998 - (72 pages) | http://www1.oecd.org/dsti/sti/s_t/biotech/prod/health.pdf |
| OECD - Working Party on Biotechnology - Economic Aspects of Biotechnologies related to Human Health - 1998 - (269 pages) | http://appli1.oecd.org/olis/1998doc.nsf/4cf568b5b90dad994125671b004bed59/f38277100c7a721bc12566b1006273a6/$FILE/11E88111.ENG |
| Amgen - home page | http://www.amgen.com/ |
| Genentech - home page | http://www.gene.com/ |
| Alza - home page | http://www.alza.com/ |
| Genzyme - home page | http://www.genzyme.com/welcome.htm |
| Chiron - home page | http://www.chiron.com/ |
| Biomedicine - home page - "make Investments in Biotech Companies which are selected according to rigorous scientific and economic criteria" | http://www.biomedicine.ch/index.html |
| Foundation for Genetic Medicine - home page - examines "a host of issues such as those regarding genetic medicine, behavioral genetics, and the ethical, legal, and social features involved" | http://www.geneticmedicine.org |
| Jeanne Clark et al., USPTO - Patent Pools: A Solution to the Problem of Access in Biotechnology Patents? - December 2000 - (17 pages) | http://www.uspto.gov/web/offices/pac/dapp/opla/patentpool.pdf |
| Royal Commission on Genetic Modifications - the Report - New Zealand | http://www.gmcommission.govt.nz/RCGM/rcgm_report.html |
| Tom Horton - Patenting our Lives and our Genes: Where does Congress stand in the coming clash? - from FTC web site - (11 pages) | http://www.ftc.gov/os/comments/intelpropertycomments/hortonthomasjarticle.pdf |
| Michal Cohen - Patent Protection of Biotechnological Inventions – Economic Perspectives and the EC Directive Analysis - August 2001 - (63 pages) | http://www.frg.eur.nl/rile/emle/Theses/cohen.pdf |
| Arti K. Rai - THE INFORMATION REVOLUTION REACHES PHARMACEUTICALS: BALANCING INNOVATION INCENTIVES, COST, AND ACCESS IN THE POST-GENOMICS ERA - Draft - Do not Cite or Quote - (44 pages) | http://www.utexas.edu/law/news/colloquium/papers/Raipaper.doc |
| Reversal of Fortune? An Assessment of the German Biotechnology Sector in Comparative Perspective - editor: Stephen H. Silvia - Economic Studies Program Series Volume 5 - (60 pages) | http://www.aicgs.org/publications/PDF/biotech.pdf |
| John R. Thomas - An Examination of the Issues Surrounding Biotechnology Patenting and Its Effect Upon Entrepreneurial Companies - Congressional Research Service The Library of Congress - August 31, 2000 - (31 pages) | http://www.cnie.org/nle/crsreports/science/st-60.pdf |
| Judith A. Johnson - Stem Cell Research - Congressional Research Service The Library of Congress -Updated August 10, 2001 - (16 pages) | http://www.cnie.org/nle/crsreports/science/st-68.pdf |
| Sean D. Murphy - Biotechnology and International Law - Social Science Research Network Electronic Paper Collection - (151 pages) | http://papers.ssrn.com/sol3/delivery.cfm/SSRN_ID266470_code010413630.pdf?abstractid=266470 |
| Commonwealth v. Lanigan, 419 Mass. 15 (1994) - Supreme Judicial Court of Massachusetts, Norfolk. - Argued Sept. 8, 1994. -Decided Nov. 18, 1994. | http://commonwealthpolice.com/2001%20Textbook%20Cases/Commonwealth/CommL/Commonwealth%20v.%20Lanigan,%20419%20Mass.%2015%20(1994).pdf |
| Diamond v. Chakrabarty, 447 U.S. 303 (1980) | http://www.ipmall.fplc.edu/hosted_resources/jepson/unit3abcd/diamond2.htm |
| Le concept du PSS en matière de génie génétique nonhumain - Document de travail de la commission Science/Recherche/Technologie du PSS - Décembre1996 - (49 pages) | http://www.sp-ps.ch/data/Pospap-f/GeniegenetiqueNonhumain.pdf |
| BioTech Forum 2/2000 - June 2000 - (30 pages) | http://bics.ch/fr/forum/2000-2.pdf |
Back
to products selection
Back to therapeutic products
Last updated: July 7, 2002